Bed Bath & Beyond Misses Q1 Earnings and EPS Estimates

+5096.46%
Upside
0.08
Market
3.90
Trefis
BBBY: Bed Bath & Beyond logo
BBBY
Bed Bath & Beyond

Bed Bath & Beyond (NASDAQ:BBBY) reported weaker than expected first quarter fiscal 2016 results on Wednesday, June 22. The company reported flat net sales of $2.74 billion, which missed the Reuters’s consensus estimate by $40 million. The company posted earnings of $0.80 per share which decreased 14% year-over-year (y-o-y) and also missed the consensus.

Comparable sales for the quarter decreased 0.5% compared to a 2.2% increase in the prior year. Although comparable sales from digital channels grew in excess of 20% in this quarter. Bed Bath & Beyond acquired e-commerce home furnishing startup One Kings Lane for an undisclosed amount last week; this acquisition, coupled with further investments in its online presence, should help the company improve on its digital capabilities in the near future.

bbby1
Bed Bath & Beyond is dealing with headwinds like many other retailers in the market. Gross margin declined this quarter to 37.4% compared to 38.1% in the prior year quarter. Gross margins have been declining in the last three years, as seen from the table below. Increases in technology-related costs, additional store setup costs, higher compensation costs and advertising expenses have led to reduced margins and profits for the company.

Relevant Articles
  1. What To Expect From Bed Bath & Beyond’s Stock Post Q1 Results?
  2. Down 54% in Six Months, What’s Next For Bed Bath & Beyond Stock?
  3. Bed Bath & Beyond Up 53% In A Month, What’s Next?
  4. Overstock.com’s Stock Rose 36% In The Last Month, Will The Rise Continue?
  5. Can Bath & Body Works Stock Rebound After A 23% Fall In a Month?
  6. Can BBBY’s Stock Trade Higher Post Q3 Results?

bbby3


A Message From Trefis Marketing
Download our eBook “Create More Accurate Forecasts and Plans” and learn: 
  • The costs of missed forecasts
  • The three reasons why companies do a poor job
  • How you can create more accurate forecasts and plans